$10.35+0.06 (+0.58%)
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States.
AdaptHealth Corp. in the Healthcare sector is trading at $10.31 with a market capitalization of $1.3B. Wall Street consensus targets $14.00 (8 analysts), implying a +35.7% move over the next 12 months. The stock is currently 23% below its 52-week high of $13.43, remaining 0.9% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $614.32M↓ | $1.47B↑ | $602.63M↑ | $591.81M↑ | $580.47M |
| Gross Profit | -$93.98M↓ | $795.82M↑ | -$55.74M↓ | -$53.90M↑ | -$76.97M |
| Operating Income | $5.49M↓ | $34.14M↓ | $67.13M↑ | $47.03M↑ | $23.17M |
| Net Income | -$16.04M↑ | -$102.77M↓ | $24.51M↑ | $14.67M↑ | -$7.21M |
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at ...
Shares of healthcare services provider AdaptHealth Corp. (NASDAQ:AHCO) jumped 2.5% in the morning session after an analyst at Truist Securities reiterated a Buy rating and a $14.00 price target on the stock.
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Since December 2025, AdaptHealth has been in a holding pattern, posting a small loss of 3% while floating around $9.94. The stock also fell short of the S&P 500’s 6.9% gain during that period.
AdaptHealth (AHCO) is drawing fresh attention after recent trading left the stock around $9.89, with returns mixed across timeframes and investors reassessing the company’s role in the U.S. home medical equipment market. See our latest analysis for AdaptHealth. The recent 1 day share price gain of 1.64% contrasts with a 30 day share price return that is down 12.48%. At the same time, the 1 year total shareholder return of 11.12% highlights how short term pressure sits alongside more...
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.